Sodium cromoglycate exerts anti-pulmonary fibrosis effects by targeting the Keap1 protein to activate Nrf2 signaling.

MLA

Liu, Xiaofeng, et al. “Sodium Cromoglycate Exerts Anti-Pulmonary Fibrosis Effects by Targeting the Keap1 Protein to Activate Nrf2 Signaling.” Bioorganic Chemistry, vol. 153, Dec. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bioorg.2024.107961.

APA

Liu, X., Huang, Y., Zhao, X., Guan, Y., Li, Y., Yuan, L., Wang, C., Ma, C., & Ma, E. (2024). Sodium cromoglycate exerts anti-pulmonary fibrosis effects by targeting the Keap1 protein to activate Nrf2 signaling. Bioorganic Chemistry, 153, N.PAG. https://doi.org/10.1016/j.bioorg.2024.107961

Chicago

Liu, Xiaofeng, Yuwei Huang, Xianchen Zhao, Yingjun Guan, Yanchun Li, Lei Yuan, Chuncheng Wang, Chao Ma, and Enlong Ma. 2024. “Sodium Cromoglycate Exerts Anti-Pulmonary Fibrosis Effects by Targeting the Keap1 Protein to Activate Nrf2 Signaling.” Bioorganic Chemistry 153 (December): N.PAG. doi:10.1016/j.bioorg.2024.107961.